Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0000950146-96-002146
Filing Date
1996-11-25
Accepted
1996-11-25 00:00:00
Documents
12
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10 10-12B/A 10644
2 TRANSACTION AGREEMENT EX-2.1 103111
3 COVANCE STOCK CERTIFICATE EX-4.1 6388
4 CREDIT AGREEMENT EX-10.5 351054
5 EMPLOYEE STOCK OWNERSHIP PLAN EX-10.6 125850
6 THE STOCK PURCHASE SAVINGS PLAN OF COVANCE INC. EX-10.7 196340
7 EMPLOYEE EQUITY PARTICIPATION PROGRAM EX-10.9 31925
8 SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN EX-10.10 27777
9 DIRECTORS' RESTRICTED STOCK PLAN EX-10.12 8800
10 DEFERRED COMPENSATION PLAN EX-10.13 8775
11 FORM OF EXECUTIVE EMPLOYMENT LETTER EX-10.15 35332
12 SELECTED PAGES FROM INFORMATION STATEMENT EX-99.1 369972
  Complete submission text file 0000950146-96-002146.txt   1278740
Mailing Address CORNING PHARMACEUTICAL SERVICES INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094528550
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12B/A | Act: 34 | File No.: 001-12213 | Film No.: 96671471
SIC: 8731 Services-Commercial Physical & Biological Research